Oncimmune Holdings plc Initiation of a Multi-Centre Trial in China
Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, and its partner, Genostics Company Limited,